110 related articles for article (PubMed ID: 29098910)
21. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
22. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
Dorin RP; Daneshmand S; Eisenberg MS; Chandrasoma S; Cai J; Miranda G; Nichols PW; Skinner DG; Skinner EC
Eur Urol; 2011 Nov; 60(5):946-52. PubMed ID: 21802833
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: a single-center experience.
Wang S; Tachimori Y; Hokamura N; Igaki H; Kishino T; Kushima R
Ann Thorac Surg; 2013 Sep; 96(3):1002-6. PubMed ID: 23810175
[TBL] [Abstract][Full Text] [Related]
24. Outcomes following therapeutic lymphadenectomy for Stage III malignant melanoma in a single unit.
Jayakar R; Yassaie E; Adams C
N Z Med J; 2018 May; 131(1474):51-59. PubMed ID: 29723179
[TBL] [Abstract][Full Text] [Related]
25. Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.
Leiter U; Eigentler TK; Häfner HM; Krimmel M; Uslu U; Keim U; Weide B; Breuninger H; Martus P; Garbe C
Ann Surg Oncol; 2015 Nov; 22(12):4073-80. PubMed ID: 25712801
[TBL] [Abstract][Full Text] [Related]
26. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden.
Spillane AJ; Pasquali S; Haydu LE; Thompson JF
Ann Surg Oncol; 2014 Jan; 21(1):292-9. PubMed ID: 24052314
[TBL] [Abstract][Full Text] [Related]
27. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
Bolenz C; Shariat SF; Fernández MI; Margulis V; Lotan Y; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Montorsi F; Bensalah K; Wood CG; Roscigno M; Langner C; Koppie TM; Raman JD; Mikami S; Michel MS; Ströbel P
BJU Int; 2009 Feb; 103(3):302-6. PubMed ID: 18990164
[TBL] [Abstract][Full Text] [Related]
29. Loco-regional nodal relapse in melanoma.
Miller EJ; Daly JM; Synnestvedt M; Schultz D; Elder D; Guerry D
Surg Oncol; 1992 Oct; 1(5):333-40. PubMed ID: 1341268
[TBL] [Abstract][Full Text] [Related]
30. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.
Zhou R; Lu D; Li W; Tan W; Zhu S; Chen X; Min J; Shang C; Chen Y
HPB (Oxford); 2019 Jul; 21(7):784-792. PubMed ID: 30878490
[TBL] [Abstract][Full Text] [Related]
31. The management of cervical lymph nodes in patients with cutaneous melanoma.
Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
[TBL] [Abstract][Full Text] [Related]
32. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer.
Dowdy SC; Borah BJ; Bakkum-Gamez JN; Weaver AL; McGree ME; Haas LR; Keeney GL; Mariani A; Podratz KC
Gynecol Oncol; 2012 Oct; 127(1):5-10. PubMed ID: 22771890
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
34. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.
Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A
Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908
[TBL] [Abstract][Full Text] [Related]
35. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.
van Akkooi AC; Bouwhuis MG; van Geel AN; Hoedemaker R; Verhoef C; Grunhagen DJ; Schmitz PI; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 Feb; 33(1):102-8. PubMed ID: 17161577
[TBL] [Abstract][Full Text] [Related]
36. The lymph node ratio has limited prognostic significance in melanoma.
Egger ME; Scoggins CR; Martin RC; Stromberg AJ; Quillo AR; McMasters KM; Callender GG
J Surg Res; 2013 Jan; 179(1):10-7. PubMed ID: 22967706
[TBL] [Abstract][Full Text] [Related]
37. Does Preventive Negative Pressure Wound Therapy (NPWT) reduce local complications following Lymph Node Dissection (LND) in the management of metastatic skin tumors?
Poirier A; Albuisson E; Bihain F; Granel-Brocard F; Perez M
J Plast Reconstr Aesthet Surg; 2022 Dec; 75(12):4403-4409. PubMed ID: 36283927
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
Leiter U; Buettner PG; Bohnenberger K; Eigentler T; Meier F; Moehrle M; Breuninger H; Garbe C
Ann Surg Oncol; 2010 Jan; 17(1):129-37. PubMed ID: 19866238
[TBL] [Abstract][Full Text] [Related]
39. Role of inguinal and pelvic lymph node dissection for primary urethral carcinoma: a systematic review.
Kochergin M; Fahmy O; Asimakopoulos AD; Gakis G
Curr Opin Urol; 2023 Jul; 33(4):288-293. PubMed ID: 37158221
[TBL] [Abstract][Full Text] [Related]
40. Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.
Henderson MA; Gyorki D; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2019 Dec; 26(13):4663-4672. PubMed ID: 31515719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
